Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years : TBI is what really matters
Autor: | Gérard Michel, C Peters, Miguel Angel Diaz, Patrick Lutz, Petr Sedlacek, Roderick Skinner, A. B. Versluys, Dorine Bresters, Peter J. Shaw, Anita Lawitschka, Maura Faraci, A. Jenkins, Brenda Gibson, Amal Al-Seraihy, Arnaud Dalissier, Nina Salooja, Chiara Cugno, Ulrike Pötschger, Kim Vettenranta, Alison D. Leiper, Mikael Sundin, Peter Bader, Tracey A. O'Brien |
---|---|
Přispěvatelé: | Brno University of Technology [Brno] (BUT), Institute of education, Queen Mary University of London (QMUL) |
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
Male
Pediatrics medicine.medical_specialty Time Factors Cross-sectional study [SHS.PSY]Humanities and Social Sciences/Psychology Graft vs Host Disease Malignancy 03 medical and health sciences 0302 clinical medicine Sex Factors Risk Factors medicine Journal Article Humans Transplantation Homologous Cumulative incidence Registries Transplantation business.industry Incidence (epidemiology) Incidence Hematopoietic Stem Cell Transplantation Infant Hematology Total body irradiation medicine.disease [SHS.ECO]Humanities and Social Sciences/Economics and Finance 3. Good health Graft-versus-host disease Cross-Sectional Studies 030220 oncology & carcinogenesis [SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health Child Preschool Hematologic Neoplasms Quality of Life [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie Female Thyroid function business Whole-Body Irradiation 030215 immunology Follow-Up Studies |
Zdroj: | Bone Marrow Transplantation Bone Marrow Transplantation, Nature Publishing Group, 2016, 51 (11), pp.1482-1489. ⟨10.1038/bmt.2016.139⟩ Bone Marrow Transplantation, 51, 1482–1489. Nature Publishing Group Bone Marrow Transplantation, 51(11), 1482-1489 |
ISSN: | 0268-3369 |
DOI: | 10.1038/bmt.2016.139⟩ |
Popis: | Younger children are considered to be more vulnerable to late effects (LE), which prompted us to study LE in patients after haematopoietic stem cell transplantation (HSCT) for a haematological malignancy before the age of 3. In this multicentre EBMT study, cumulative incidence (CI) and severity of endocrine LE, central nervous system complications and secondary malignancies at 5, 10, 15 and 20 years of follow-up were assessed. Risk factors (RF) like gender, diagnosis, age at and year of HSCT, TBI- or chemo-conditioning and GVHD were analysed. CI of any LE was 0.30, 0.52, 0.66 and 0.72 at 5, 10, 15 and 20 years after HSCT, respectively. In 25% of the patients, LE were severe at a median follow-up of 10.4 years. In multivariate analysis, only TBI was a RF for having any LE and for thyroid dysfunction and growth disturbance. Female gender was a RF for delayed pubertal development. Some more insight could be gained by descriptive analysis regarding the role of TBI and GVHD on the severity of LE. Although only five selected LE have been studied and median follow-up is relatively short, the incidence and severity of these LE are considerable but not different from what has been found in older children and TBI is the main RF.Bone Marrow Transplantation advance online publication, 27 June 2016; doi:10.1038/bmt.2016.139. |
Databáze: | OpenAIRE |
Externí odkaz: |